K011972

Substantially Equivalent

DIRECT BILIRUBIN REAGENT

Applicant: Intersect Systems, Inc.
Product code: CIG
Advisory panel: Clinical Chemistry
Date received: 2001-06-25
Decision date: 2001-08-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Longview, WA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.